Literature DB >> 6442633

Vascular endothelial cell injury in progressive systemic sclerosis and other connective tissue diseases.

O Meyer, T Haïm, A Dryll, J Lansaman, A Ryckewaert.   

Abstract

The growth inhibition of in vitro vascular endothelial cell cultures by sera from patients with connective tissue diseases was studied. Seven out of 30 sera from patients with progressive systemic sclerosis (PSS) exhibited a cytotoxic effect. The cytotoxic serum factor(s) was not specific to patients with PSS, it was also demonstrated in sera from patients with other connective tissue diseases with vascular symptoms (11 out of 27 sera from patients with a mixed connective tissue disease, MCTD; 5 out of 34 sera from patients with a systemic lupus erythematosus, SLE). The cytotoxic effect was not specific for vascular endothelial cells, it was also found on fibroblast cells cultures. Inhibitor(s) of cell growth in vitro was independent of antinuclear and anticytoplasmic antibodies and appeared as a common feature of all connective tissue diseases with vascular symptoms.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6442633

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  9 in total

Review 1.  Anti-endothelial cell antibodies in systemic sclerosis.

Authors:  Y Renaudineau; R Revelen; Y Levy; K Salojin; B Gilburg; Y Shoenfeld; P Youinou
Journal:  Clin Diagn Lab Immunol       Date:  1999-03

Review 2.  The endothelium: its role in scleroderma.

Authors:  J D Pearson
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

3.  Prolonged increase in digital blood flow following iloprost infusion in patients with systemic sclerosis.

Authors:  M Rademaker; R H Thomas; G Provost; J A Beacham; E D Cooke; J D Kirby
Journal:  Postgrad Med J       Date:  1987-08       Impact factor: 2.401

4.  Active proliferation of telangiectases in skin of patients with progressive systemic sclerosis (PSS).

Authors:  S Kazandjian; P Bruneval; J N Fiessinger; J P Camilleri; E Housset
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

5.  Endothelial cytotoxic activity (ECA) in sera of patients with livedo racemosa generalisata Ehrmann.

Authors:  F Drenk; D Lubach; C Schwabe; H Deicher
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

6.  Detection of antilymphocyte antibodies in patients with scleroderma using three different techniques.

Authors:  M T Labro; A Perianin; M F Kahn
Journal:  Clin Rheumatol       Date:  1984-12       Impact factor: 2.980

7.  Measurement and characterisation of circulating anti-endothelial cell IgG in connective tissue diseases.

Authors:  J Rosenbaum; B E Pottinger; P Woo; C M Black; S Loizou; M A Byron; J D Pearson
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

Review 8.  Vascular disease in scleroderma.

Authors:  Fredrick M Wigley
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

9.  Studies on endothelial cell cytotoxic activity in sera of patients with progressive systemic sclerosis, Raynaud syndrome, rheumatoid arthritis, and systemic lupus erythematosus.

Authors:  F Drenk; H Mensing; A Serbin; H Deicher
Journal:  Rheumatol Int       Date:  1985       Impact factor: 2.631

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.